The company states: "BioCryst announced that the FDA has approved oral, once-daily ORLADEYO, or berotralstat, for prophylaxis to prevent attacks of hereditary angioedema in adults and pediatric patients 12 years and older. In the pivotal Phase 3 APeX-2 trial, ORLADEYO significantly reduced attacks at 24 weeks, and this reduction was sustained through 48 weeks. HAE patients who completed 48 weeks of treatment saw reductions in their HAE attack rates, from a mean of 2.9 attacks per month at baseline to a mean of 1.0 attacks per month after 48 weeks of therapy. In the long-term open label APeX-S trial, patients completing 48 weeks of therapy had a mean attack rate of 0.8 attacks per month. ORLADEYO was safe and well tolerated in both trials. The most frequently reported adverse reactions in patients receiving ORLADEYO compared with placebo were gastrointestinal reactions. These reactions generally occurred early after initiation of treatment with ORLADEYO, became less frequent with time and typically self-resolved. HAE patients note a significant treatment burden associated with existing prophylactic therapy. In addition to reducing HAE attack rate, data from APeX-2 show that patients reported meaningful improvements in both quality of life and overall patient-reported satisfaction, and significant reductions in their monthly use of standard of care on-demand medicine, while taking oral, once-daily ORLADEYO (150 mg)."

Francesca's "announced that the company, along with its subsidiaries, has voluntarily filed for relief under chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on December 3, 2020. francesca's intends to use these proceedings to implement a sale process focused on the company's core retail locations as well as its promising digital expansion and new brand launches. The company will be filing a motion seeking authorization to pursue an auction and sale process under section 363 of the U.S. Bankruptcy Code and expects to move through the sale process as expeditiously as possible. The company is committed to working with its lenders and stakeholders towards a speedy and successful resolution of the cases. francesca's(R) has received a commitment from its existing lender, Tiger Finance, LLC, for a $25M debtor-in-possession financing facility. The new facility, which is subject to Court approval, will enable the Company to continue to operate the business and meet its financial obligations, including the timely payment of employee wages and benefits, continued provision of customer orders and shipments, and payment of other obligations during the chapter 11 cases. This funding will support the company for the duration of the sale process, providing francesca's with the financial runway and flexibility to run a thorough process to maximize value. After thoroughly evaluating all strategic alternatives, the Board of Directors unanimously agreed that pursuing a sale of the business is a necessary step forward for the business."

the domestic market in November 2020, demand, or RPK, for GOL's flights was up by 5% over October 2020 and supply, or ASK, decreased by 3% over October 2020. GOL's domestic load factor was 84.5% in November. GOL did not operate regular international flights during the month.

This is the lowest level of holdings since July 1st.

In a regulatory filing, Lemonade disclosed that its CFO Timothy Bixby sold 40K shares of common stock on December 1st in a total transaction size of $2.79M. The sale represents about 13% of his total owned.

LGI Homes announced 960 home closings in November 2020, up from 748 home closings in November 2019, representing year-over-year growth of 28.3%. In addition, the company ended the first eleven months of 2020 with 7,709 home closings, a 16.1% increase over 6,638 home closings during the first eleven months of 2019. As of the end of November 2020, the company had 114 active selling communities. "We are proud to announce another record breaking month of home closings," said Eric Lipar, Chief Executive Officer and Chairman of LGI Homes. "This was our best November on record and the second best month of closings overall in our history. Based on this outstanding November performance and our current view of the backlog available to close in December, we are updating our full year closings guidance to reflect our expectation of closing between 8,800 and 9,200 homes in 2020."

On an interview on CNBC's Mad Money, Jesse Singh said, "We had a really strong quarter that capped off a strong year." Azek is seeing good trends in the remodel business, Singh noted. The company is only playing in 20% of the market, leaving a huge runway ahead, he added. The single largest raw material Azek uses is recycled plastics. That is giving the company a huge cost advantage versus using virgin product, Singh said.

Shares of Kraton are up 7.7% to $30 after announcing a $50M extension to its credit facility. The company states: "Kraton announced that it has entered into an amendment to its senior secured asset-based revolving credit facility, or "ABL Facility". The amendment extends the maturity date of the ABL Facility from January 2023 to December 2025 and provides for a $50 million increase in aggregate commitment to $300 million."

American Eagle announced that its board has updated the record and payment dates of the previously-deferred first quarter 2020 cash dividend, which originally was declared on March 26, 2020 and deferred on April 2, 2020 in response to store closures resulting from the COVID-19 pandemic. The $0.1375 per share cash dividend is now payable on December 30, 2020 to stockholders of record at the close of business on December 16, 2020.

The dividend is payable on December 30 to shareholders of record as of December 18.